Meet Our Scientists at ASGCT

April 29 - May 2, 2019 at the Washington Hilton

Gene therapies and gene-modified cell therapies are providing life-saving treatment to many patients. Meet with our team at ASGCT to discuss how your development program can benefit from our state-of-the-art facilities for manufacturing and testing services.

Explore what's next at Merck!

Visit the Event Website

Don’t miss our technical experts:

Presentations

• Development of a Scalable, Transient Lentivirus Production Platform
  April 30, 5:30 pm - 5:45 pm
  Speaker: Henry George, Head of Viral and Gene Therapy Bioprocessing & Vector Producing Cell Lines
• Determination of AAV purity by AUC sedimentation velocity for Viral Vectors used in Cell and Gene Therapy
  April 30, 5:45 pm - 6:00 pm
  Speaker: Kamran Anwar, PhD, Senior Associate Scientist in Virology Development Services

Posters

• High Titer Lentivirus Production in Suspension Cell Culture
  Authors: Andrea Spencer & Henry George
  Wednesday, May 1, 5:00 pm - 6:00 pm
• Replication Competent Retrovirus Testing for Gene Therapy Vectors: Current Methodology and Regulatory Expectations
  Author: Leyla Diaz
  Monday, April 29, 5:00 pm - 6:00 pm